V2 receptor antagonists in cystic kidney diseases: An exciting step towards a practical treatment

被引：6

作者：

Bennett, WM

机构：

[1] Legacy Transplant Serv, Portland, OR USA

[2] NW Renal Clin, Portland, OR USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 04期

关键词：

D O I：

10.1681/ASN.2005020136

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：838 / 839

页数：2

共 9 条

[1] Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells [J].

Belibi, FA ;

Reif, G ;

Wallace, DP ;

Yamaguchi, T ;

Olsen, L ;

Li, H ;

Helmkamp, GM ;

Grantham, JJ .

KIDNEY INTERNATIONAL, 2004, 66 (03) :964-973

[2] Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort [J].

Chapman, AB ;

Guay-Woodford, LM ;

Grantham, JJ ;

Torres, VE ;

Bae, KT ;

Baumgarten, DA ;

Kenney, PJ ;

King, BF ;

Glockner, JF ;

Wetzel, LH ;

Brummer, ME ;

O'Neill, WC ;

Robbin, ML ;

Bennett, WM ;

Klahr, S ;

Hirschman, GH ;

Kimmel, PL ;

Thompson, PA ;

Miller, JP .

KIDNEY INTERNATIONAL, 2003, 64 (03) :1035-1045

[3] Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist [J].

Gattone, VH ;

Wang, XF ;

Harris, PC ;

Torres, VE .

NATURE MEDICINE, 2003, 9 (10) :1323-1326

[4] Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure - A randomized controlled trial [J].

Gheorghiade, M ;

Gattis, WA ;

O'Connor, CM ;

Adams, KF ;

Elkayam, U ;

Barbagelata, A ;

Ghali, JK ;

Benza, RL ;

McGrew, FA ;

Klapholz, M ;

Ouyang, J ;

Orlandi, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16) :1963-1971

[5] Murine models of polycystic kidney disease: molecular and therapeutic insights [J].

Guay-Woodford, LM .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (06) :F1034-F1049

[6]

OHNISHI A, 1995, J PHARMACOL EXP THER, V272, P546

[7] Cyclic AMP, at the hub of the cystic cycle [J].

Torres, VE .

KIDNEY INTERNATIONAL, 2004, 66 (03) :1283-1285

[8] Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease [J].

Torres, VE ;

Wang, XF ;

Qian, Q ;

Somlo, S ;

Harris, PC ;

Gattone, VH .

NATURE MEDICINE, 2004, 10 (04) :363-364

[9] Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK [J].

Wang, XF ;

Gattone, V ;

Harris, PC ;

Torres, VE .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :846-851

← 1 →